Today's After-Hours Stock Movers:

MicroVision, Inc. (NASDAQ: MVIS) 55.3% LOWER; MicroVision announced selected financial information about its fourth quarter of 2019. Total revenue in the fourth quarter was approximately $4.6 million, consisting of $4.1 million of product shipments, $0.4 million of contract revenue, and $0.1 million of royalty revenue. Gross profit in the quarter was approximately $1.2 million.

Revolve Group (NYSE: RVLV) 21% LOWER; reported Q4 EPS of $0.12, $0.01 better than the analyst estimate of $0.11. Revenue for the quarter came in at $147.56 million versus the consensus estimate of $152.56 million.

SmileDirectClub (NASDAQ: SDC) 19% LOWER; reported Q4 EPS of ($0.25), $0.16 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $197 million versus the consensus estimate of $199.93 million. SmileDirectClub sees 2020 revenue of $1-1.1 billion, versus the consensus of $1.14 billion.

Big 5 Sporting Goods Corporation (Nasdaq: BGFV) 15.5% LOWER; For the fiscal 2019 full year, as previously reported, net sales were $996.5 million, compared to net sales of $987.6 million for the fiscal 2018 full year. Same store sales increased 1.2% in fiscal 2019 versus the prior year. Net income for fiscal 2019 was $8.4 million, or $0.40 per diluted share. Net loss for fiscal 2018 was $3.5 million, or $0.17 per basic share, including charges of $0.09 per basic share as previously reported.

Insulet (NASDAQ: PODD) 13.4% LOWER; reported Q4 EPS of $0.08, $0.03 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $209.4 million versus the consensus estimate of $199.5 million.

Weight Watchers (NASDAQ: WW) 9.2% HIGHER; reported Q4 EPS of $0.42, $0.04 better than the analyst estimate of $0.38. Revenue for the quarter came in at $333 million versus the consensus estimate of $330.63 million. Weight Watchers International, Inc. sees FY2020 EPS of $2.15-$2.40, versus the consensus of $2.11. Weight Watchers International, Inc. sees FY2020 revenue of $1.6 billion, versus the consensus of $1.48 billion.

Toll Brothers (NYSE: TOL) 8% LOWER; reported Q1 EPS of $0.41, $0.04 worse than the analyst estimate of $0.45. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.45 billion.

Supernus Pharma (NASDAQ: SUPN) 7.4% LOWER; reported Q4 EPS of $0.62, $0.02 better than the analyst estimate of $0.60. Revenue for the quarter came in at $100.45 million versus the consensus estimate of $111.53 million. Supernus Pharma sees FY2020 revenue of $360-390 million, versus the consensus of $407.7 million.

Penumbra, Inc. (NYSE: PEN) 6.9% LOWER; reported Q4 EPS of $0.22, $0.02 better than the analyst estimate of $0.20. Revenue for the quarter came in at $145.3 million versus the consensus estimate of $141.38 million.

Planet Fitness (NYSE: PLNT) 6.4% LOWER; reported Q4 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $191.5 million versus the consensus estimate of $189.62 million.

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) 6.1% HIGHER; Full Year 2019 Total Revenues of $16.5 Million including NUZYRA® (omadacycline) Net Sales of $11.5 Million

Unisys Corp. (NYSE: UIS) 6% LOWER; reported Q4 EPS of $0.60, $0.16 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $741.5 million versus the consensus estimate of $754.13 million.

Matador Resources (NYSE: MTDR) 5.4% HIGHER; reported Q4 EPS of $0.39, $0.11 better than the analyst estimate of $0.28.

Alarm.com (NASDAQ: ALRM) 5.3% HIGHER; reported Q4 EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $140.5 million versus the consensus estimate of $113.6 million. Alarm.com Holdings, Inc. sees FY2020 EPS of $1.48-$1.49, versus the consensus of $1.46. Alarm.com Holdings, Inc. sees FY2020 revenue of $547-557.5 million, versus the consensus of $543.8 million.

Virgin Galactic Holdings (NYSE: SPCE) 4.5% LOWER; reports Q4 net loss of $73 million. Revenue for the quarter came in at $529 thousand, versus $1.28 million reported last year.

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) 4.1% LOWER; announced results from a Phase III clinical trial (EPIONE) of tradipitant for the treatment of pruritus in atopic dermatitis (AD) in adults. The EPIONE study did not meet its primary endpoint in reduction of pruritus across the overall study population. However, the antipruritic effect of tradipitant was robust in the mild AD study population. Mild AD represents over 60% of the total AD population in the U.S.1, 2 The EPIONE study continued to demonstrate that tradipitant is safe and well-tolerated.

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) 3.7% HIGHER; reports Q4 results.

Inspire Medical Systems (NYSE: INSP) 3.7% HIGHER; reported Q4 EPS of ($0.38), $0.02 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $26.9 million versus the consensus estimate of $23.84 million. Inspire Medical Systems sees FY2020 revenue of $115-119 million, versus the consensus of $108.8 million.

Salesforce (NYSE: CRM) 3.4% LOWER; reported Q4 EPS of $0.66, $0.11 better than the analyst estimate of $0.55. Revenue for the quarter came in at $4.85 million versus the consensus estimate of $4.75 million. Salesforce sees FY2021 EPS of $3.16-$3.18, versus the consensus of $3.10. Salesforce sees FY2021 revenue of $21-21.1 billion, versus the consensus of $20.93 billion. Salesforce sees Q1 2021 EPS of $0.70-$0.71, versus the consensus of $0.70. Salesforce sees Q1 2021 revenue of $4.875-4.885 billion, versus the consensus of $4.84 billion. Also announced that Keith Block has stepped down as co-CEO of Salesforce and Marc Benioff is Chair and CEO of the company. Block is remaining as Advisor to the CEO.

The Walt Disney Company (NYSE: DIS) 1.7% LOWER; Board of Directors announced today that Bob Chapek has been named Chief Executive Officer, The Walt Disney Company, effective immediately. Mr. Chapek most recently served as Chairman of Disney Parks, Experiences and Products. Robert A. Iger assumes the role of Executive Chairman and will direct the Companys creative endeavors, while leading the Board and providing the full benefit of his experience, leadership and guidance to ensure a smooth and successful transition through the end of his contract on Dec. 31, 2021